Clin2
NCT06061848Possibly a fitRecruiting

Grass pollen allergy shot with vitamin D

Allergic Rhinitis Due to Grass Pollen

Part of Immune system & allergy clinical trials.

This study tests if adding vitamin D to a new type of allergy shot (ILIT) works better than standard allergy drops for grass pollen allergy. It may help if you have moderate to severe seasonal allergy symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
360 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You have moderate to severe grass pollen allergy (with symptom score 8 or higher).
  • You have not had allergy shots or drops before.
  • Your vitamin D level is between 25 and 75 nmol/L and you are not taking extra vitamin D.
  • You do not have asthma that is not controlled, other significant diseases, or conditions like autoimmune disease, cancer, or heart disease.
  • You are not pregnant or nursing, and you are not allergic to the study medication.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04898283Recruiting· Phase 3
Allergy shot study for grass and cypress pollen symptoms

This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.

Valladolid, Castille and León
NCT07199257Not yet recruiting· Phase 3
Testing a new shot for seasonal allergies not controlled by sprays

This trial tests a new injection called GR1802 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments. It aims to see if this medicine can help reduce symptoms during pollen season.

Wuhan, Hubei
NCT07154342Recruiting· Phase 3
Testing a new antibody for seasonal allergies

This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.

Wuhan, Hubei
NCT04891237Recruiting· Phase 3
Grass and olive allergy vaccine trial for teens to older adults

This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.

Tarancón, Cuenca
NCT06846385Recruiting· Phase 2/Phase 3
Testing a new shot for severe seasonal hay fever

This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.

Beijing, Beijing Municipality
NCT07115342Recruiting
Probiotics and vitamin D for hay fever relief

This study tests whether taking a combination of probiotics (good bacteria) and vitamin D can help reduce hay fever symptoms. It may be a good option if your vitamin D is low and you haven't used probiotics recently.

Tanta, Gharbia Governorate

Hear when a new Allergic Rhinitis Due to Grass Pollen trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.